LH Labcorp Holdings Inc.

30일간 8-K 3건. 10/28 실적 발표 예정.

종가$323.75
시가총액$258억
업종헬스케어
다음 실적 발표2026-10-28
PER25.7배
매출 성장(최근 4분기)+6.4%
영업이익률10%
애널리스트 순상향률0.0%
목표가 상승여력+6.6%
공매도 거래 비중47%
1년 수익률+12%

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncolog

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목